Biotech

All Articles

Basilea scores $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's job building new antifungals has obtained a significant increase coming fro...

Capricor sells Europe legal rights to late-stage DMD treatment for $35M

.Possessing already scooped up the USA legal rights to Capricor Rehabs' late-stage Duchenne muscle d...

FDA junks adcomm for Applied's rare illness medication

.After dismissing the selection date for Applied Therapies' metabolic condition drug govorestat, the...

Novo inks $600M NanoVation package to examine genetic drugs ex-liver

.Novo Nordisk is actually continuing its press into hereditary medications, consenting to compensate...

Innovent web links cytokine to intestines cancer cells feedbacks

.Innovent Biologics has helped make the case that its own checkpoint inhibitor-cytokine fusion prote...

Merck, Daiichi ADC reaches goal in phase 3 bronchi cancer cells study

.A phase 3 test of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (A...

Rakovina strengthens artificial intelligence focus with collab to select cancer cells intendeds

.Five months after Rakovina Therapeutics pivoted towards expert system, the cancer-focused biotech h...

Ascendis' dwarfism medicine favorites in stage 3, threatens BioMarin

.Ascendis Pharma has emerged as a potential threat to BioMarin's Voxzogo, disclosing period 3 develo...

Despite ph. 3 miss, Alkeus sees course ahead of time for eye health condition resource

.Though Alkeus Pharmaceuticals' oral eye health condition resource fell short to dramatically lower ...

Kairos goes public along with $6M IPO to finance trials of cancer cells medicine

.Along with a trio of biotechs striking the Nasdaq on Friday, it was actually quick and easy to over...